ARIAD Pharmaceuticals Inc (NASDAQ:ARIA)

8.13
Delayed Data
As of Feb 27
 -0.04 / -0.49%
Today’s Change
4.90
Today|||52-Week Range
9.13
+18.34%
Year-to-Date

Today’s Trading

Previous close8.17
Today’s open8.18
Day’s range8.05 - 8.35
Volume4,915,815
Average volume (3 months)6,519,948
Market cap$1.5B
Dividend yield--
Data as of 3:59pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)+41.61%
Earnings growth (this year)-17.91%
Earnings growth (next 5 years)+41.39%
Revenue growth (last year)+131.36%
P/E ratioNM
Price/Sales12.18
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NKTRNektar Therapeutics+0.09+0.69%
KERXKeryx Biopharmaceuti...+0.23+1.93%
INCRINC Research Holding...-0.58-1.90%
FGENFibroGen Inc+0.81+2.61%
Data as of 4:00pm ET, 02/27/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$105.4M
Annual profit (last year)-$162.6M
Net profit margin-154.25%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Harvey J. Berger
Senior VP-Corporate Development &
Operations
Pierre F. Dodion
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account